Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

UFS's international advisory board holds first meeting
2009-11-28

Members of the International Advisory Board of the UFS in discussion with Prof. Dennis Francis (right), who is appointed as Dean of the Faculty of Education from the beginning of 2010. With him are Prof. Alice Pell from Cornell University in the USA and Dr Uri Ofir from Evalnet in Switzerland.
Photo:  Leatitia Pienaar


The International Advisory Board of the University of the Free State (UFS) had its first meeting on the Main Campus in Bloemfontein this week. It coincided with the launch of the six research clusters of the UFS.

Prof. Aldo Stroebel, Director: Internationalisation at the UFS, says internationalisation is a strategic priority to reach the University’s strategic goals. Internationalisation will bring a global awareness at all levels and will serve as a co-shaping factor and an instrument to produce well-rounded, internationally competent staff and students. It will also be an instrument to promote diversity, advance the UFS’s international standing and initiate and promote international collaborative research.

The advisory board will advise and guide the UFS leadership in the internationalisation process. He said the board would provide strategic guidance to the internationalisation efforts of the UFS and bring cutting-edge expertise to bear on the internationalisation policies, strategies and action plans of the institution.

Its members will help ensure that the University leadership is aware of relevant international trends and opportunities, and the board will use their experience to advise on appropriate actions. They will also act as advocates for the University in their own spheres of influence.

The board consists of Dr Jane Knight of the Ontario Institute for Studies in Education, University of Toronto, Canada; Prof. Alice Pell of the Cornell University, USA; Prof. Masafumi Nagao of the International Christian University, Japan; Dr Khotso Mokhele of Impala Platinum Holdings, South Africa; Prof. Joseph Stetar of the Seton Hall University, USA; and Dr Uri Ofir of Evalnet, Switzerland. Prof. Jonathan Jansen, Rector and Vice-Chancellor of the UFS, is the Chairperson of the board.

Prof. Stroebel says the UFS is honoured to have people of international standing and who are highly regarded in various fields on the board to guide the institution in its internationalisation endeavours.

Media release
Issued by: Lacea Loader
Deputy Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
27 November 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept